SIC
CORT icon

SJS Investment Consulting’s Corcept Therapeutics CORT Stock Holding History

SJS Investment Consulting’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.61K Buy
99
+96
+3,200% +$5.8K ﹤0.01% 1143
2026
Q1 		$121 Sell
3
-20
-87% -$748 ﹤0.01% 2104
2025
Q4 		$802 Buy
23
+14
+156% +$1.1K ﹤0.01% 1375
2025
Q3 		$748 Hold
9
– – ﹤0.01% 1106
2025
Q2 		$661 Sell
9
-7
-44% -$508 ﹤0.01% 1014
2025
Q1 		$1.83K Hold
16
– – ﹤0.01% 763
2024
Q4 		$807 Sell
16
-4
-20% -$210 ﹤0.01% 1082
2024
Q3 		$926 Hold
20
– – ﹤0.01% 1098
2024
Q2 		$650 Hold
20
– – ﹤0.01% 1204
2024
Q1 		$504 Sell
20
-1
-5% -$24 ﹤0.01% 1285
2023
Q4 		$683 Sell
21
-3
-13% -$82 ﹤0.01% 1118
2023
Q3 		$654 Buy
24
+4
+20% +$116 ﹤0.01% 1109
2023
Q2 		$445 Buy
20
+6
+43% +$138 ﹤0.01% 1202
2023
Q1 		$304 Sell
14
-3
-18% -$66 ﹤0.01% 1282
2022
Q4 		$345 Buy
17
+4
+31% +$100 ﹤0.01% 1316
2022
Q3 		$0 Buy
+13
New +$348 ﹤0.01% 1127
2022
Q1 		$0 Buy
+3
New +$64 ﹤0.01% 816

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SJS Investment Consulting's CORT Position: Q2 2026 in Review

SJS Investment Consulting increased its Corcept Therapeutics (CORT) stake by 3,200% in Q2 2026, buying an estimated $5.8K and bringing the position to 99 shares worth $8.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

SJS Investment Consulting first reported a position in CORT in Q1 2022 and has held it in 17 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • SJS Investment Consulting held 99 shares of Corcept Therapeutics worth $8.61K as of Q2 2026.
  • SJS Investment Consulting bought 96 Corcept Therapeutics shares in Q2 2026, an estimated $5.8K.
  • Corcept Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1143 holding.
  • SJS Investment Consulting first reported a position in Corcept Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.